• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】33694

【品名】cyclohexanecarbaldehyde

【CA登记号】2043-61-0

【 分 子 式 】C7H12O

【 分 子 量 】112.17168

【元素组成】C 74.95% H 10.78% O 14.26%

与该中间体有关的原料药合成路线共 7 条

合成路线1

该中间体在本合成路线中的序号:(IV)

The acylation of 11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione (I) with isobutyric anhydride in pyridine gives the 16,17,21-triester (III), which is condensed with cyclohexanecarbaldehyde (IV) by means of HCl and HClO4 in dioxane yielding the cyclic ketal (Va-b) as a diastereomeric mixture. Finally, this mixture is resolved by preparative HPLC over Lichrosorb RP-18 affording the desired (R)-isomer, the target compound. Alternatively, the monoacylation of the ketal 11beta,16alpha,17alpha,21-tetrahydroxypregan-1,4-diene-3,20-dione 16,17-O-cyclohexylmethylene ketal (VI) with isobutyric anhydride (II) by means of K2CO3 in acetone gives the previously described diastereomeric mixture (Va-b), which is resolved by crystallization in ethanol/water.

1 Calatayud, J.; Conde, J.R.; Luna, M. (Byk Elmu SA); Acetals and esters of 16alpha-hydroxyprednisolone and fluocinolone. BE 1005876; CH 683343; DE 4129535; ES 2034893; FR 2666585; GB 2247680; JP 1992257599; US 5482934 .
2 Gutterer, B.; Amschler, H.; Flockerzi, D. (Byk Gulden Lomberg Chemische Fabrik GmbH); Process for R-epimer enrichment of 16,17-acetal derivs. of 21-acyloxy pregnan-1,4-dien-11beta,16alpha,17alpha-triol-3,20-dione derivs.. DE 19635498; WO 9809982 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Va) 38916 2-[(4aR,5S,6aS,8S,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate C32H44O7 详情 详情
(Vb) 38917 2-[(4aR,5S,6aS,8R,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate C32H44O7 详情 详情
(I) 32675 (8S,9S,10R,11S,13S,14S,16R,17S)-17-glycoloyl-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one C21H28O6 详情 详情
(II) 22334 1-methylpropionic anhydride 97-72-3 C8H14O3 详情 详情
(III) 38915 2-[(10R,11S,13S,16R,17S)-11-hydroxy-16,17-bis(isobutyryloxy)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl 2-methylpropanoate C33H46O9 详情 详情
(IV) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
(VI) 38918 (4aR,5S,6aS,6bS,9aR)-8-cyclohexyl-6b-glycoloyl-5-hydroxy-4a,6a-dimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one C28H38O6 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

Treatment of cyclohexanecarboxaldehyde (I) with sulfur monochloride produced the dimeric disulfide (II). After condensation of (II) with 3-amino-1-propanol (III), reduction with NaBH4 afforded diamine (IV). Subsequent N-methylation of (IV) to give (VI) was achieved by condensation with formaldehyde, followed by NaBH4 reduction of the resulting oxazine (V). Reductive cleavage of the disulfide group of (VI) using LiAlH4 provided thiol (VII). Optionally, nitrosation of the sulfhydryl group of (VII) by means of tert-butyl nitrite gave rise to the nitrosothio derivative (VIII). Further coupling of this compound with diclofenac (IX) in the presence of DCC and DMAP furnished the title ester. Alternatively, the title compound was prepared by esterification of mercapto alcohol (VII) with diclofenac, followed by S-nitrosation of the resulting ester (X).

1 Bandarage, U.K.; et al.; Nitrosothiol esters of diclofonecac: Synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs. J Med Chem 2000, 43, 21, 4005.
2 Bandarage, U.K.; et al.; NMI-377, a nitric oxide-donating diclofenac derivative with gastroprotective properties. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 81.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
(II) 33695 1-[(1-formylcyclohexyl)disulfanyl]cyclohexanecarbaldehyde C14H22O2S2 详情 详情
(III) 18522 3-amino-1-propanol 156-87-6 C3H9NO 详情 详情
(IV) 33696 3-[([1-[(1-[[(3-hydroxypropyl)amino]methyl]cyclohexyl)disulfanyl]cyclohexyl]methyl)amino]-1-propanol C20H40N2O2S2 详情 详情
(V) 33697 bis[1-(1,3-oxazinan-3-ylmethyl)cyclohexyl] disulfide; 3-[(1-[[1-(1,3-oxazinan-3-ylmethyl)cyclohexyl]disulfanyl]cyclohexyl)methyl]-1,3-oxazinane C22H40N2O2S2 详情 详情
(VI) 33698 3-[([1-[(1-[[(3-hydroxypropyl)(methyl)amino]methyl]cyclohexyl)disulfanyl]cyclohexyl]methyl)(methyl)amino]-1-propanol C22H44N2O2S2 详情 详情
(VII) 33699 3-[methyl[(1-sulfanylcyclohexyl)methyl]amino]-1-propanol C11H23NOS 详情 详情
(VIII) 33700 1-[[(3-hydroxypropyl)(methyl)amino]methyl]-N-oxocyclohexanesulfenamide C11H22N2O2S 详情 详情
(IX) 33701 Diclofenac; 2-[2-(2,6-Dichloroanilino)phenyl]acetic acid C14H11Cl2NO2 详情 详情
(X) 33702 3-[methyl[(1-sulfanylcyclohexyl)methyl]amino]propyl 2-[2-(2,6-dichloroanilino)phenyl]acetate C25H32Cl2N2O2S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XI)

Coupling between ethyl 3-aminopropionate (I) and N-Boc-glycine (II) by means of EDC and HOBt affords the protected dipeptide (III). After acidic Boc group cleavage in (III), the N-deprotected dipeptide (IV) is acylated by 3,3,3-triphenylpropionic acid (V) to produce amide (VI). Saponification of the ethyl ester group of (VI) yields acid (VII). This is coupled with (R)-1-Boc-3-(aminomethyl)piperidine (VIII) to afford amide (IX), which is further subjected to acidic N-Boc group cleavage. The resultant piperidine derivative (X) is then reductively condensed with cyclohexanecarboxaldehyde (XI) in the presence of NaBH(OAc)3 to furnish the title compound.

1 Kimura, T.; Noguchi, K.; Otake, N.; Uchiyama, M.; Naya, A.; Sagara, Y.; Numazawa, T.; Fujikawa, T. (Banyu Pharmaceutical Co., Ltd.); Novel amide derivs.. EP 1213281; WO 0107406 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17639 beta-Alanine, ethyl ester; ethyl 3-aminopropanoate 924-73-2 C5H11NO2 详情 详情
(II) 18066 N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid 4530-20-5 C7H13NO4 详情 详情
(III) 57638 ethyl 3-({2-[(tert-butoxycarbonyl)amino]acetyl}amino)propanoate C12H22N2O5 详情 详情
(IV) 57639 ethyl 3-[(2-aminoacetyl)amino]propanoate C7H14N2O3 详情 详情
(V) 57640 3,3,3-Triphenylpropionic acid; Tritylacetic acid 900-91-4 C21H18O2 详情 详情
(VI) 57641 ethyl 3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoate C28H30N2O4 详情 详情
(VII) 57642 N-{2-[(3,3,3-triphenylpropanoyl)amino]acetyl}-beta-alanine C26H26N2O4 详情 详情
(VIII) 57643 tert-butyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate C11H22N2O2 详情 详情
(IX) 57644 tert-butyl (3R)-3-({[3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoyl]amino}methyl)-1-piperidinecarboxylate C37H46N4O5 详情 详情
(X) 57645 N-{2-oxo-2-[(3-oxo-3-{[(3S)piperidinylmethyl]amino}propyl)amino]ethyl}-3,3,3-triphenylpropanamide C32H38N4O3 详情 详情
(XI) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XI)

The primary amino group of 4-(aminomethyl)piperidine (I) was protected by conversion to the phthalimide (III) upon heating with phthalic anhydride (II). After coupling of piperidine (III) with 1-naphthylacetic acid (IV) to give amide (V), hydrazinolysis of the phthalimido group of (V) liberated the primary amine (VI). Alkylation of (VI) with N-(4-bromobutyl)phthalimide (VII) furnished the secondary amine (VIII), which was further protected with a tert-butoxycarbonyl group to provide (IX). The phthaloyl group of (IX) was then removed by hydrazinolysis, yielding amine (X). This was subjected to reductive alkylation with cyclohexanecarboxaldehyde (XI) in the presence of NaBH4 to afford the cyclohexylmethyl amine (XII). After purification as the di-Boc derivative, acid cleavage of the tert-butyl carbamate groups provided the title compound.

1 Yoneda, Y.; et al.; Synthesis of diaminobutane derivatives as potent Ca2+-permeable AMPA receptor antagonists. Bioorg Med Chem Lett 2001, 11, 19, 2663.
2 Ito, M.; Yoneda, Y.; Kawagoe, K.; Yasukouchi, T.; Kito, F.; Mimura, T.; Kawajiri, S.; Sugimura, M.; Saito, M.; Tatematu, T.; Discovery of diaminobutane derivatives as Ca2+ -permeable AMPA receptor antagonists. Bioorg Med Chem 2002, 10, 5, 1347.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19349 4-piperidinylmethylamine; 4-piperidinylmethanamine; 4-(Aminomethyl)piperidine 7144-05-0 C6H14N2 详情 详情
(II) 11900 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride 85-44-9 C8H4O3 详情 详情
(III) 51132 2-(4-piperidinylmethyl)-1H-isoindole-1,3(2H)-dione C14H16N2O2 详情 详情
(IV) 51133 Planofix; alpha-Naphthylacetic acid; 1-Naphthaleneacetic acid; 1-Naphthylacetic acid; alpha-Naphthaleneacetic acid; Naphthalene-1-acetic acid 86-87-3 C12H10O2 详情 详情
(V) 51134 2-([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)-1H-isoindole-1,3(2H)-dione C26H24N2O3 详情 详情
(VI) 51135 1-[4-(aminomethyl)-1-piperidinyl]-2-(1-naphthyl)-1-ethanone C18H22N2O 详情 详情
(VII) 17163 N-(4-Bromobutyl)phthalimide; 2-(4-Bromobutyl)-1H-isoindole-1,3(2H)-dione 5394-18-3 C12H12BrNO2 详情 详情
(VIII) 51136 2-[4-[([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)amino]butyl]-1H-isoindole-1,3(2H)-dione C30H33N3O3 详情 详情
(IX) 51137 tert-butyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate C35H41N3O5 详情 详情
(X) 51138 tert-butyl 4-aminobutyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate C27H39N3O3 详情 详情
(XI) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
(XII) 51139 tert-butyl 4-[(cyclohexylmethyl)amino]butyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate C34H51N3O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VII)

Saponification of ethyl adamantyloxyacetate (I), followed by treatment of the resultant carboxylic acid (II) with oxalyl chloride gives rise to acid chloride (III). This is then condensed with benzyl (triphenylphosphoranylidene)acetate (IV) to produce the phosphoranylidene keto ester (V). Subsequent oxidative cleavage of phosphorane (V) with oxone under phase transfer conditions leads to diketo ester (VI). Cyclization between diketo ester (VI), cyclohexanecarboxaldehyde (VII) and ammonium acetate in hot AcOH affords imidazole (VIII). The benzyl ester group of (VIII) is removed by catalytic hydrogenolysis, yielding acid (IX), which is further coupled with benzyl 3-aminobenzoate (X) to furnish amide (XI). Finally, benzyl ester hydrogenolysis in the presence of Pd/C provides the target compound (1,2).

1 Gastrin and cholecystokinin receptor ligands. JP 2002529455; US 6479531; WO 0027823 .
2 Kalindjian, S.B.; Mesens, J.L.; Black, J.W.; Hull, R.A.D.; Shankley, N.P.; Andries, L.J. (James Black Foundation Ltd.; Janssen Pharmaceutica NV); Pharmaceutical compsns. comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands. WO 0185167 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 64427 ethyl 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetate C14H22O3 详情 详情
(II) 64428 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetic acid C12H18O3 详情 详情
(III) 64429 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetyl chloride C12H17ClO2 详情 详情
(IV) 22668 benzyl 2-(triphenylphosphoranylidene)acetate C27H23O2P 详情 详情
(V) 64430 phenylmethyl 3-oxo-4-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)-2-(triphenyl-lambda~5~-phosphanylidene)butanoate C39H39O4P 详情 详情
(VI) 64449 phenylmethyl 2,3-dioxo-4-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)butanoate C21H24O5 详情 详情
(VII) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
(VIII) 64450 phenylmethyl 2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazole-4-carboxylate C28H36N2O3 详情 详情
(IX) 64461 2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazole-4-carboxylic acid C21H30N2O3 详情 详情
(X) 64462 phenylmethyl 3-aminobenzoate C14H13NO2 详情 详情
(XI) 64463 phenylmethyl 3-[({2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazol-4-yl}carbonyl)amino]benzoate C35H41N3O4 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

 

1 彭璃螭,赣开智.2004.一种哮啮治疗药物环索奈德的新的制备方法,发明专7f4V开说明书,CN1626546A
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66189 2-((6aS,7R,8aR,8bR)-7-hydroxy-6a,8a,10,11a-tetramethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate   C28H38O7 详情 详情
(II) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
(III) 38917 2-[(4aR,5S,6aS,8R,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate C32H44O7 详情 详情

合成路线7

该中间体在本合成路线中的序号:(IV)

 

1 Pierluigi R,MacDonald P.2007.Improved process for the preparation of ciclesonide. W0 2007056181
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22334 1-methylpropionic anhydride 97-72-3 C8H14O3 详情 详情
(II) 66190 (6aS,7R,8aR,8bR,11aS,12bR)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one   C24H32O6 详情 详情
(III) 66191 (6aR,7S,8aS,8bS,11aR,12bS)-7-hydroxy-8b-isobutyryl-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one   C26H36O5 详情 详情
(IV) 38916 2-[(4aR,5S,6aS,8S,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate C32H44O7 详情 详情
(IV) 33694 cyclohexanecarbaldehyde 2043-61-0 C7H12O 详情 详情
Extended Information